KMDA FY 2023 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena

KMDAKamada Ltd.

$520M

FY 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$143M+10.2% YoY

Gross Profit

$55M38.9% margin

Operating Income

$10M7.1% margin

Net Income

$8M5.8% margin

EPS (Diluted)

$0.15

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

-$2M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$355M

Total Liabilities

$111M

Stockholders' Equity

$244M

Cash & Equivalents

$56M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$143M	$129M	+10.2%
Gross Profit	$55M	$47M	+18.8%
Operating Income	$10M	$5M	+122.1%
Net Income	$8M	-$2M	+456.9%